These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10050693)

  • 1. Thromboembolic disease in total knee arthroplasty.
    Lonner JH
    Am J Knee Surg; 1999; 12(1):43-8. PubMed ID: 10050693
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
    Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
    J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty.
    Lotke PA; Lonner JH
    Clin Orthop Relat Res; 2006 Nov; 452():175-80. PubMed ID: 16957642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of aspirin for thromboembolic disease in total joint arthroplasty.
    Lotke PA
    Am J Knee Surg; 1999; 12(1):61-3. PubMed ID: 10050696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic disease after total knee replacement: experience of 5100 cases.
    Clayton RA; Gaston P; Watts AC; Howie CR
    Knee; 2009 Jan; 16(1):18-21. PubMed ID: 19008109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence and prevention of symptomatic thromboembolic disease following unicompartmental knee arthroplasty.
    Lombardi AV; Berend KR; Tucker TL
    Orthopedics; 2007 May; 30(5 Suppl):46-8. PubMed ID: 17549868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty.
    Pellegrini VD; Donaldson CT; Farber DC; Lehman EB; Evarts CM
    Clin Orthop Relat Res; 2006 Nov; 452():21-7. PubMed ID: 16906107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
    Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
    Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study.
    Samama CM; Ravaud P; Parent F; Barré J; Mertl P; Mismetti P
    J Thromb Haemost; 2007 Dec; 5(12):2360-7. PubMed ID: 17908282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
    Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute pulmonary embolism: the clinical conundrum.
    Wang ZL
    Chin Med J (Engl); 2012 Jan; 125(2):352-66. PubMed ID: 22340572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk vs benefits for thromboembolic disease after total joint surgery.
    Lotke PA
    Chest; 2005 Jun; 127(6):2297-8. PubMed ID: 15947368
    [No Abstract]   [Full Text] [Related]  

  • 13. BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study.
    Turpie AG; Fisher WD; Bauer KA; Kwong LM; Irwin MW; Kälebo P; Misselwitz F; Gent M;
    J Thromb Haemost; 2005 Nov; 3(11):2479-86. PubMed ID: 16241946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of symptomatic pulmonary embolism in patients undergoing total hip and knee arthroplasty: clinical guideline of the American Academy of Orthopaedic Surgeons.
    Lachiewicz PF
    Instr Course Lect; 2009; 58():795-804. PubMed ID: 19385587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic diseases.
    Wakefield TW; Caprini J; Comerota AJ
    Curr Probl Surg; 2008 Dec; 45(12):844-99. PubMed ID: 18984095
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of mechanical and other adjuncts.
    Westrich GH
    Am J Knee Surg; 1999; 12(1):64-71. PubMed ID: 10050697
    [No Abstract]   [Full Text] [Related]  

  • 17. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee--a prospective study.
    Lindahl TL; Lundahl TH; Nilsson L; Andersson CA
    Thromb Haemost; 1999 Jan; 81(1):18-21. PubMed ID: 10348713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement.
    Agnelli G; Haas S; Ginsberg JS; Krueger KA; Dmitrienko A; Brandt JT
    J Thromb Haemost; 2007 Apr; 5(4):746-53. PubMed ID: 17408408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic disease after total knee surgery: a critical review.
    Lotke PA; Elia EA
    Instr Course Lect; 1990; 39():409-12. PubMed ID: 2186131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolism after total knee arthroplasty: intermittent pneumatic compression and aspirin prophylaxis.
    Larson CM; MacMillan DP; Lachiewicz PF
    J South Orthop Assoc; 2001; 10(3):155-63; discussion 163. PubMed ID: 12132827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.